We conclude that GLUT8 mediates hepatic fructose uptake and HFrD-induced macrosteatosis in vivo and that substrate delivery mechanisms at the hepatocyte cell surface are a mechanism by which to modulate NAFLD pathogenesis. This evidence concerns the gene SLC2A8 and metabolic dysfunction-associated steatotic liver disease.